Microtome Market by Product (Instruments, Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End-User (Hospital, Clinical Laboratories) - Global Forecast to 2027

The microtomes market is estimated to increase at a CAGR of 6.5 percent from USD 129 million in 2019 to USD 177 million in 2027. Due to rising healthcare expenditures, digital pathology, and the high prevalence of cancer, this industry is witnessing tremendous expansion. The market's expansion is projected to be hampered by a scarcity of qualified specialists.

During the forecast period, the rotary microtomes segment is expected to increase the most.

Some of the most often used modules on the market are rotary microtomes, cryostat microtomes, and vibrating microtomes. In 2018, the rotary microtomes segment held the biggest market share, and it is predicted to grow at the fastest rate throughout the forecast period. This is due to the advantages that rotary microtomes provide, such as the capacity to cut tiny sections (2–3 mm). Rotary microtomes are great for cutting serial sections and can be easily converted to any form of tissue sectioning (hard, delicate, or fatty).

In 2018, the manual microtome segment will dominate the microtome tools market.

The microtomes market is divided into three categories based on technology: manual, semi-automated, and fully automated microtomes. In 2018, the manual microtomes segment held the biggest market share. In comparison to automatic and semi-automatic microtomes, manual microtomes are less expensive and easier to use. These aspects are assisting its market acceptance.

In 2018, the largest regional market for microtomes was North America.

North America, Europe, Asia Pacific, and the Rest of the World make up the microtomes market. North America led the way in terms of market share in 2018, followed by Europe. The easy availability of advanced technologies, expanding opportunities for advanced cancer diagnostic testing and screening, favorable reimbursement scenario for anatomic pathology diagnostic tests, rising healthcare expenditures, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are all driving the microtomes market in North America.